Article
Erythroid Atypical Chemokine Receptor 1 Deficiency Aggravates Immune-Mediated Kidney Disease.
Journal of the American Society of Nephrology : JASN - 1 Apr 2026
Artinger Katharina, Novitzky-Basso Igor, Klötzer Konstantin A, Anto-Michel Nathaly, Schabhüttl Corinna, Gutjahr Julia Christine, Samus Maryna, Hub Elin, Kirsch Alexander H, Leitinger Daniel, Wernitznig Stefan, Umeizudike Theophilus, Pollheimer Marion, Ulvmar Maria H, Mooslechner Agnes A, Bacon Andrea, Eller Philipp, Kroneis Thomas, Kratky Dagmar, Rosenkranz Alexander R, Eller Kathrin, Rot Antal
Abstract excerpt
KEY POINTS: Selective erythroid atypical chemokine receptor 1 deficiency exacerbated disease activity in experimental GN via changes of the myeloid lineage. Activated monocytes and profibrogenic phenotypes of macrophages underlaid the kidney phenotype observed in erythroid-silent individuals. Genetically modified mouse models showed pathomechanisms of kidney diseases in patients of West African ancestry with...
Topics
Join the communities discussing this publication.
